Earnings History Data for Leap Therapeutics (LPTX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Leap Therapeutics

Leap Therapeutics, Inc. is a biopharmaceutical company. It develops novel therapeutics for the treatment of cancer. Leap Therapeutics, Inc. is based in Cambridge, United States.

Release Date	Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
18-03-2024	PM	LPTX	Leap Therapeutics	56.00	-0.46	-0.56	0.00	Leap Therapeutics GAAP EPS of -$0.46 beats by $0.10 [3/18/2024 7:10 AM]	2.16	-0.05 (-2.26%)	2.21	0.0 (0.00%)	1.24 - 10.20	136,323	180,000	5,370
Leap Therapeutics GAAP EPS of -$0.46 beats by $0.10 [3/18/2024 7:10 AM] Leap Therapeutics files for $200M mixed shelf offering [3/18/2024 10:56 AM]
12-11-2021	PM	LPTX	LEAP THERAPEUTICS, INC.	219.94	-0.14	-0.11	-0.09	Leap Therapeutics reports Q3 results [11/12/2021 7:40 AM]	2.45	0.07 (2.72%)	2.42	0.03 (1.26%)	1.33 - 4.17	2,867,333	1,310,000	21,602
Leap Therapeutics EPS misses by $0.03, misses on revenue [11/12/2021 7:40 AM] Leap Therapeutics Reports Third Quarter 2021 Financial Results [Nov-12-21 07:00AM]
13-08-2021	PM	LPTX	LEAP THERAPEUTICS, INC.	94.28	-0.12	-0.13	-0.12	Leap Therapeutics EPS in-line, beats on revenue [8/13/2021 7:19 AM]	1.68	0.02 (1.20%)	1.66	0.0 (0.00%)	1.33 - 3.24	359,673	720,000	2,290
Leap Therapeutics EPS in-line, beats on revenue [8/13/2021 7:19 AM] Here's What Leap Therapeutics, Inc.'s (NASDAQ:LPTX) Shareholder Ownership Structure Looks Like [Aug-12-21 05:43AM] Leap Therapeutics Reports Second Quarter 2021 Financial Results and Upcoming Data Presentation [Aug-13-21 07:00AM] Leap Therapeutics, Inc. (LPTX) Reports Q2 Loss [Aug-13-21 08:25AM]
14-05-2021	PM	LPTX	LEAP THERAPEUTICS, INC.	96.66	-0.12	-0.11	-0.55	Leap Therapeutics reports Q1 results [5/14/2021 8:52 AM]	1.56	0.08 (5.41%)	1.51	0.03 (2.03%)	1.43 - 3.24	309,753	380,000	10,155
Leap Therapeutics reports Q1 results [5/14/2021 8:52 AM] Leap Therapeutics and Flagship Biosciences Develop Image Analysis RNAscope Assay for Prospective Trial Enrollment [May-12-21 08:00AM] Leap Therapeutics Reports First Quarter 2021 Financial Results [May-14-21 08:00AM] Leap Therapeutics, Inc. (LPTX) Reports Q1 Loss, Lags Revenue Estimates [May-14-21 09:15AM]
12-03-2021	PM	LPTX	LEAP THERAPEUTICS, INC.	128.26	-0.09	-0.08	-0.33	Leap Therapeutics EPS in-line, misses on revenue [3/12/2021 7:20 AM]	2.45	0.06 (2.51%)	2.43	0.04 (1.67%)	1.15 - 3.24	605,984	648,099	6,287
Leap Therapeutics, Inc. (LPTX) Reports Q4 Loss, Lags Revenue Estimates [Mar-12-21 08:15AM] Leap Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results [Mar-12-21 07:00AM]
12-11-2020	PM	LPTX	LEAP THERAPEUTICS, INC.	95.45	-0.09	-0.12	-0.33	Leap Therapeutics EPS beats by $0.04, beats on revenue [11/12/2020 7:19 AM]	1.54	-0.05 (-3.14%)	1.58	-0.01 (-0.63%)	0.57 - 3.18	686,815	1,136,206	2,417

13-08-2020	PM	LPTX	LEAP THERAPEUTICS, INC.	111.12	-0.12	-0.17	-0.37	Leap Therapeutics EPS beats by $0.06, misses on revenue [8/13/2020 7:12 AM]	1.97	0.07 (3.68%)	1.91	0.01 (0.53%)	0.57 - 3.18	327,497	668,485	4,400